Magaz, Marta; Giudicelli-Lett, Heloïse; Nicoară-Farcău, Oana; Rajoriya, Neil; Goel, Ashish; Raymenants, Karlien; Hillaire, Sophie; Crespo, Gonzalo; Téllez, Luis; Elkrief, Laure; Fondevila, Constantino; Orts, Lara; Nery, Filipe; Shukla, Akash; Larrue, Hélène; Fundora, Yiliam; Degroote, Helena; Aguilera, Victoria; LLop, Elba; Turco, Laura; ... (2023). Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome. Transplantation, 107(6), pp. 1330-1340. Lippincott Williams & Wilkins 10.1097/TP.0000000000004444
Text
Liver_Transplantation_for_Porto_Sinusoidal.265.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (904kB) |
BACKGROUND AND AIMS
Porto-sinusoidal vascular liver disorder (PSVD) is a rare disease that occasionally requires liver transplantation (LT), despite usually presenting preserved liver function. There remains a paucity of data pertaining to LT in PSVD. The aim was to identify features associated with post-LT outcomes in PSVD.
METHODS
Retrospective multicentre study of 79 patients who received LT for PSVD.
RESULTS
Median post-LT follow-up was 37 (range 1-261) mo. Refractory ascites 24 (30%), hepatic encephalopathy 16 (20%), and hepatopulmonary syndrome 13 (16.3%) were the most frequent indications for LT. Hepatocellular carcinoma was the indication in only 2 patients. Twenty-four patients died, 7 due to liver and 17 to non-liver related causes. Post-LT survival was 82.2%, 80.7%, and 68.6% at 1, 2, and 5 y, respectively. Post-LT survival was significantly better in patients without (n = 58) than in those with a persistent severe PSVD-associated condition (n = 21). Pre-LT hyperbilirubinemia levels and creatinine >100 µmol/L were also independently associated with poor survival. Six patients (7.6%) required a second LT. Recurrence of PSVD was confirmed by liver biopsy in only 1 patient and in 3 further patients it was likely.
CONCLUSIONS
LT in PSVD is associated with an acceptable outcome in the absence of associated severe conditions. However, persistence of a severe associated condition, pre-LT high bilirubin levels, or creatinine >100 µmol/L impact outcome, and these are features that should be considered when evaluating PSVD patients for LT. PSVD recurrence is possible after LT and needs to be explored, at least, in cases of posttransplant portal hypertension.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology 04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine |
UniBE Contributor: |
Becchetti, Chiara, Berzigotti, Annalisa |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0041-1337 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
12 Dec 2022 12:27 |
Last Modified: |
24 May 2023 00:12 |
Publisher DOI: |
10.1097/TP.0000000000004444 |
PubMed ID: |
36479977 |
BORIS DOI: |
10.48350/175651 |
URI: |
https://boris.unibe.ch/id/eprint/175651 |